| ST_0635 | Farnesoid X receptor | 3OOF | Homo sapiens | Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)benzoic acid |
| ST_0636 | Farnesoid X receptor | 3OOK | Homo sapiens | Crystal structure of human FXR in complex with 4-({(2S)-2-[2-(4-chlorophenyl)-5,6-difluoro-1H-benzimidazol-1-yl]-2-cyclohexylacetyl}amino)-3,5-difluor |
| ST_0637 | Farnesoid X receptor | 3L1B | Homo sapiens | Complex Structure of FXR Ligand-binding domain with a tetrahydroazepinoindole compound |
| ST_0638 | Farnesoid X receptor | 5WZX | Homo sapiens | Structural basis for a pentacyclic oleanane-type triterpenoid as a ligand of FXR |
| ST_0639 | Farnesoid X receptor | 1OT7 | Homo sapiens | Structural Basis for 3-deoxy-CDCA Binding and Activation of FXR |
| ST_0640 | Farnesoid X receptor | 4OIV | Homo sapiens | Structural basis for small molecule NDB as a selective antagonist of FXR |
| ST_0641 | Farnesoid X receptor | 1OSV | Homo sapiens | STRUCTURAL BASIS FOR BILE ACID BINDING AND ACTIVATION OF THE NUCLEAR RECEPTOR FXR |
| ST_0642 | Farnesoid X receptor | 3HC5 | Homo sapiens | FXR with SRC1 and GSK826 |
| ST_0643 | Farnesoid X receptor | 3HC6 | Homo sapiens | FXR with SRC1 and GSK088 |
| ST_0644 | Farnesoid X receptor | 4WVD | Homo sapiens | Identification of a novel FXR ligand that regulates metabolism |
| ST_0645 | Farnesoid X receptor | 5IAW | Homo sapiens | Novel natural FXR modulator with a unique binding mode |
| ST_0646 | Farnesoid X receptor | 5Z12 | Homo sapiens | A structure of FXR/RXR |
| ST_0647 | Farnesoid X receptor | 3OKH | Homo sapiens | Crystal structure of human FXR in complex with 2-(4-chlorophenyl)-1-[(1S)-1-cyclohexyl-2-(cyclohexylamino)-2-oxoethyl]-1H-benzimidazole-6-carboxylic a |
| ST_0648 | Farnesoid X receptor | 3OKI | Homo sapiens | Crystal structure of human FXR in complex with (2S)-2-[2-(4-chlorophenyl)-1H-benzimidazol-1-yl]-N,2-dicyclohexylethanamide |
| ST_0649 | Farnesoid X receptor | 3BEJ | Homo sapiens | Structure of human FXR in complex with MFA-1 and co-activator peptide |
| ST_0650 | Farnesoid X receptor | 4QE6 | Homo sapiens | FXR with CDCA and NCoA-2 peptide |
| ST_0651 | Farnesoid X receptor | 4QE8 | Homo sapiens | FXR with DM175 and NCoA-2 peptide |